Form 4 for JAZZ Jazz Pharmaceuticals plc
Accepted 2023-03-07 00:00:00 ET · period of report 2023-03-03 · accession 0001765581-23-000032 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-03-07 | 2023-03-06+ | JAZZ | Larkin Finbar | SVP, Technical Ops | S - Sale+OE | $142.19 | -3,781 | 23.9K | -14% | -$537.6K |
| D | 2023-03-07 | 2023-03-06 | JAZZ | Larkin Finbar | SVP, Technical Ops | M - OptEx | $58.72 | +1,706 | 25.6K | +7% | +$100.2K |
| D | 2023-03-07 | 2023-03-03 | JAZZ | Larkin Finbar | SVP, Technical Ops | A - Grant | $0.00 | +4,373 | 23.9K | +22% | $0 |
| D | 2023-03-07 | 2023-03-06 | JAZZ | Larkin Finbar | SVP, Technical Ops | M - OptEx | $0.00 | -1,706 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2023-03-07 | S | D | 2,075 | $140.76 | 21,779 | D | — | — | (F4) Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $140.7578 to $140.7656 The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| 2 | Common | Ordinary Shares | 2023-03-06 | S | D | 1,706 | $143.92 | 23,854 | D | — | — | |
| 3 | Common | Ordinary Shares | 2023-03-06 | M | A | 1,706 | $58.72 | 25,560 | D | — | — | |
| 4 | Common | Ordinary Shares | 2023-03-03 | A | A | 4,373 | $0.00 | 23,854 | D | — | — | (F2) Includes 72 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on November 30, 2022. |
| 5 | Derivative | Non-Qualified Stock Option (right to buy) | 2023-03-06 | M | D | 1,706 | $0.00 | 0 | D | $58.72 · — to 2023-05-02 | 1,706 Ordinary Shares | (F5) These options were granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vested over four years measured from the grant date, May 3, 2013, with 1/4th vesting on April 9, 2014 and the remainder vesting in 36 equal monthly installments thereafter. The option is fully vested and exercisable as of the date of this Form. |